Suchergebnisse - "Kanemura, Hiroaki"

PubPharm (16)

1

Efficacy of Crizotinib After Entrectinib Resistance Due to MET Polysomy in ROS1-Rearranged NSCLC : A Case Report

enthalten in: JTO clinical and research reports | 2023

von Takakura, T. | Kanemura, H. | Sakai, K. | +3

2

Correction : Implication of changes in PD-L1 expression during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen in esophageal squamous cell carcinoma

enthalten in: Esophagus : official journal of the Japan Esophageal Society | 2023

von Mitani, S. | Kawakami, H. | Shiraishi, O. | +8

ErratumFor: Esophagus. 2023 Apr;20(2):281-289. - PMID 36484900

3

Implication of changes in PD-L1 expression during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF) regimen in esophageal squamous cell carcinoma

enthalten in: Esophagus : official journal of the Japan Esophageal Society | 2023

von Mitani, S. | Kawakami, H. | Shiraishi, O. | +8

ErratumIn: Esophagus. 2023 Jan 20;:. - PMID 36658273

4

The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers : a multicenter retrospective study

enthalten in: Frontiers in immunology | 2023

von Kurosaki, T. | Chamoto, K. | Suzuki, S. | +17

5

Successful treatment with atezolizumab combination chemotherapy in a patient with high-grade fetal adenocarcinoma of the lung : A case report

enthalten in: Thoracic cancer | 2023

von Fujimoto, K. | Watanabe, S. | Yasuda, Y. | +10

6

Yolk Sac Tumor in a Recurrence of Colonic Adenocarcinoma With Shared Mutations in APC and TP53 Genes : A Case Report

enthalten in: International journal of surgical pathology | 2022

von Otani, T. | Kanemura, H. | Kimura, M. | +7

7

The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC

enthalten in: JTO clinical and research reports | 2022

von Kanemura, H. | Hayashi, H. | Tomida, S. | +16

8

Interstitial lung disease associated with capmatinib therapy in a patient with non-small cell lung cancer harboring a skipping mutation of MET exon 14

enthalten in: Thoracic cancer | 2021

von Kanemura, H. | Takeda, M. | Shimizu, S. | +1

9

Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck : a single-center retrospective study

enthalten in: Anti-cancer drugs | 2021

von Kurosaki, T. | Mitani, S. | Tanaka, K. | +13

10

Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy?

enthalten in: Translational lung cancer research | 2020

von Kanemura, H. | Takeda, M. | Nakagawa, K.

CommentOn: J Thorac Oncol. 2020 Jan;15(1):80-90. - PMID 31622732